Ilaris 150 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FMEE9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,858
Award facts
- Contract value 100% obligated
- $87,858.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $87,858.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of ILARIS 150 mg/ml vials. The contract is firm fixed-price with no set-aside designation and has an ultimate completion date of February 3, 2026. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
The PPV-G GEN V represents the DLA's broader $30.3 billion acquisition strategy to establish multiple regional prime vendor contractors capable of supplying a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group serves as a critical supplier within this framework, with demonstrated capability across diverse therapeutic categories including specialty pharmaceuticals, biologics, vaccines, and emergency medications. As a qualified prime vendor, the company fulfills recurring medical supply needs for military healthcare facilities worldwide through firm fixed-price delivery orders issued by the DLA's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FMEE9?
SPE2DR26FMEE9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FMEE9 worth?
The government has obligated $87,858 on SPE2DR26FMEE9.
Is contract SPE2DR26FMEE9 an order under another contract?
Yes. SPE2DR26FMEE9 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEE9 competed?
The extent of competition for SPE2DR26FMEE9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award